APA

Simonneau G., Torbicki A., Hoeper M. M., Delcroix M., Karlócai K., Galiè N., Degano B., Bonderman D., Kurzyna M., Efficace M., Giorgino R. & Lang I. M. (20130318). Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. : The European respiratory journal.

Chicago

Simonneau Gérald, Torbicki Adam, Hoeper Marius M, Delcroix Marion, Karlócai Kristóf, Galiè Nazzareno, Degano Bruno, Bonderman Diana, Kurzyna Marcin, Efficace Michela, Giorgino Ruben and Lang Irene M. 20130318. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. : The European respiratory journal.

Harvard

Simonneau G., Torbicki A., Hoeper M. M., Delcroix M., Karlócai K., Galiè N., Degano B., Bonderman D., Kurzyna M., Efficace M., Giorgino R. and Lang I. M. (20130318). Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. : The European respiratory journal.

MLA

Simonneau Gérald, Torbicki Adam, Hoeper Marius M, Delcroix Marion, Karlócai Kristóf, Galiè Nazzareno, Degano Bruno, Bonderman Diana, Kurzyna Marcin, Efficace Michela, Giorgino Ruben and Lang Irene M. Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. : The European respiratory journal. 20130318.